Become a Certified Professional Impact Analyst

One way to improve the effectiveness of international development programs is to equip professionals with the skills of impact analysis: assessment, finance, and evaluation. The Impact Bridges Group has a strong working relationship with the faculty members at Queen’s University in charge of the design and delivery of a training program that focuses on these skills.

The program, referred to as CPIA (Certified Professional Impact Analyst), offers three courses: Discover Impact, Finance Impact, Measure Impact. Individuals who complete all three courses and a qualifying exam, are eligible for the designation of Certified Professional Impact Analyst (CPIA).

Three Courses. One Designation.

 
CPIA-Courses.png
 
image2.png

The three CPIA courses are designed for all professionals involved in designing, financing, implementing, monitoring, or evaluating social interventions, public policies, or international development projects. Each course is one-week, and comprises lectures, in-class discussions, and applied case studies to ensure that participants can apply the concepts they learn to practical projects.

The upcoming course is Discover Impact (May 13-17, 2019). For more information on CPIA or to register for the program, please visit www.cpia.queensu.ca

Click here to view the CPIA brochure.

 

Exciting New Opportunity:

Take the Certified Professional Impact Analyst (CPIA) courses with financial support from Impact Bridges Group

Impact Bridges Group is committed to helping organizations maximize the impact of their social development projects and improve efficiency and distributive justice.

To that end, we’re proud to partner with the Certified Professional Impact Analyst (CPIA) program at Queen’s University, in order to support select industry professionals in pursuing this exciting educational opportunity. Impact Bridges group will cover 50% of the cost of tuition for one selected participant in each of the three CPIA courses.

rawpixel-651327-unsplash.jpg

The CPIA program provides participants the opportunity to learn to rigorously identify, design, finance, implement, monitor and evaluate social interventions, public policies and international development projects.

The program consists of three courses:
Discover Impact. Learn how to identify, define, and value sources of impact.
Finance Impact. Learn about project finance and how to enter the world of results-based financing and impact investing.
Measure Impact. Learn how to rigorously collect evidence and analyze data.
Those who complete all three courses are eligible to write an exam and receive the designation of CPIA-I. More details about the program and course dates are available at https://cpia.queensu.ca.

Social and international development professionals intending to pursue a CPIA course or the complete certification are eligible to apply for the Impact Bridges Group seat and the 50% reduction in tuition. Applications will be evaluated based on relevant experience, the anticipated benefit of the course to your or your institution’s projects, policies, or programs, and demonstrated interest in enhancing the impact of your initiatives.

Application Questions

To apply, please submit a maximum two-page response to the following questions, along with a C.V. and a letter indicating organizational support (if applicable), to info@impactbridgesgroup.com with “CPIA Tuition Support” in the subject line.

Name:
Phone Number:
Email Address:
Address:
Position and Organizational Affiliation:

Please list the CPIA course(s) you are planning to apply to and for which you are seeking Impact Bridge’s Group’s support.

  1. What is your experience with social or international development work? Please include other experience you feel is relevant to your application here.

  2. Why are you interested in the CPIA program? What do you hope to get out of the course? How do you see the skills gained in this course as contributing to your current or future initiatives? Please include evidence of your or your organization’s commitment to pursuing impact in your activities and/or evidence of your intention to move in this direction.

 
 

 

the next generation impact bond

GW_Business.png

INSTITUTE FOR CORPORATE RESPONSIBILITY

 

 

New Research Project - Coming Soon

RWANDA SELENIUM SUPPLEMENTATION CLINICAL TRIAL

This three-year randomized controlled trial, involved 300 HIV-positive patients, who had not begun antiretroviral therapy (ART). The results showed a 48 per cent decrease in the rate of CD4 decline. CD4 cells are a type of white blood cell that plays a crucial role in protecting the body from infection. The HIV virus attacks and destroys the CD4 cells of a person’s immune system. CD4 counts are a strong indicator of the progression of the disease. A low CD4 count is one of the ways to tell if a person living with HIV has progressed to stage 3 infection (AIDS). Funded by Global Benefit Canada, now IBG, the study was conducted by medical professionals in Rwanda, and supported by Canadians Dr. Don Warren, ND. Dr. Ed Mills and Dr. Dugald Seely. 

Selenium is an essential trace mineral known for its antioxidant properties and for its role in preserving immune competency. The main source of selenium in the body comes from food; the amount of selenium in food depends on where the food is grown or raised. The level of selenium in soils varies significantly around the world. Dr. Harold Foster, a medical geographer, theorized that the reason AIDS was so prevalent in East and South Africa was because of the low levels of selenium in the soil. The study shows that selenium supplementation may be a positive way to slow the progression of the disease in HIV positive persons.

Coming soon

Use of Diagnostic Technology to Improve Impact

 
Research-DropBot.jpg

Sci-Bots

Sci-Bots Inc. is developing the next generation of tools to automate and miniaturize biology and chemistry. Their portable and easy-to-use DropBot platform uses a technology called digital microfluidics to transform lab experiments into digital objects that can be optimized, shared to the cloud, and replicated anywhere in the world with perfect fidelity.

DropBot is an open-source Digital Microfluidic (DMF) automation system developed in the University of Toronto’s Wheeler Lab. It can be used to manipulate discrete droplets on the surface of an array of electrodes coated with a hydrophobic insulator. DMF has many applications in the fields of biology and chemistry, including diagnostics, cell-based assays, and chemical synthesis. The DropBot features a modular and extensible design, an intuitive user interface, and is capable of driving up to 120 independent channels. It also provides dynamic impedance sensing which enables closed-loop control and real-time measurement of:

  • drop position
  • instantaneous drop velocity
  • electrostatic driving force

DropBot is built around an Arduino-based instrument and is controlled by a custom software interface called Microdrop. Users can activate/deactivate electrodes on the DMF device by clicking their mouse on the webcam video overlay, providing an intuitive interface with real-time visual feedback. Sequences of actuation steps can be pre-programmed and run automatically, enabling fully automated operation. The system is designed as a loosely-coupled set of modules, which means that it is relatively easy to extend the hardware and/or software capabilities.

DropBot was featured in a recent article (Ng. et al., "A Digital Microfluidic System for Serological Immunoassays in Remote Settings" Sci. Trans. Med. 2018, 10) describing our 2016 field-study in a Kenyan refugee camp where we tested droplet-sized blood samples for measles and rubella antibodies. The story got picked up by severalnews outlets and even made national TV. This story is of particular interest, because the instrument developed for this project formed the basis for the new DropBot and ultimately led to the founding of Sci-Bots!

 

 

Fio Corporation

Embed data capture into routine workflow

Fionet connects mobile companion devices that guide diagnosis, treatment and record-keeping with web-based tools for remote oversight and reporting.

Fionet-60975.jpg
 
Deki Reader

IMPROVE FIELD PERFORMANCE AND OVERSIGHT OF RAPID DIAGNOSTIC TESTING

The Deki Reader provides step-by-step guidance for performing rapid diagnostic tests and delivers an objective analysis of results. Meanwhile, Fionet provides test-by-test traceability.

The Deki Reader is a rugged, in vitro diagnostic device for use with commercially available lateral flow immunoassays (commonly known as rapid diagnostic tests) and Fionet mobile software.

The Deki Reader provides:

  • Step-by-step guidance for performing rapid diagnostic tests
  • Quality checks for rejecting misprocessed tests
  • An objective analysis of test results
  • Test-by-test traceability via records uploaded to Fionet
  • Feedback from remote managers using Fionet two-way messaging
  • Configurable workflows for standardizing care delivery and data capture